Foldyna, Borek http://orcid.org/0000-0002-2466-4827
Eslami, Parastou
Scholtz, Jan-Erik
Baltrusaitis, Kristin
Lu, Michael T.
Massaro, Joseph M.
D’Agostino, Ralph B. Sr
Ferencik, Maros
Aerts, Hugo J. W. L.
O’Donnell, Christopher J.
Hoffmann, Udo
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FO993/1)
National Institutes of Health (5K24HL113128-07, U01HL092040, U01HL092022)
National Heart, Lung, and Blood Institute (N01- HC-25195, HL076784, AG028321, HL070100, HL060040, HL080124, HL071039, HL077447, HL107385)
Article History
Received: 24 January 2019
Revised: 1 April 2019
Accepted: 4 April 2019
First Online: 2 May 2019
Compliance with ethical standards
:
: Dr. Foldyna received unrelated funding from the German Research Foundation (DFG), project 290004377 (FO993/1) and support from the National Institutes of Health 5K24HL113128-07. Dr. Hoffmann received unrelated Research Grants (U01HL092040, U01HL092022, Heart Flow Inc., MedImmune; KOWA Inc.). Dr. Ferencik reports receiving an unrelated grant from the American Heart Association. This work was further supported by the NIH Heart, Lung, and Blood Institute’s Framingham Heart Study (contract nos. N01- HC-25195, HL076784, AG028321, HL070100, HL060040, HL080124, HL071039, HL077447, HL107385). The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: Some study subjects or cohorts have been previously reported in the scope of prior Framingham Heart Study investigations. This study used in part data and resources from the Framingham Heart Study of the National Heart, Lung, and Blood Institute of the National Institutes of Health and Boston University School of Medicine. Dr. Borek Foldyna, Dr. Udo Hoffmann, and Dr. Christopher J. O’Donnell have had full access to all the study data and take responsibility for the data integrity and the analysis accuracy.
: • retrospective• observational• performed at one institution (study center)